{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"authors":[{"name":"Fergal M Waldron","affiliation":"University of Aberdeen","affiliation_url":"","username":"fergal-waldron","link":"","image":{"source":"https://content.protocols.io/files/pxjh5yye.jpg","placeholder":"https://content.protocols.io/files/pxjh5yye.jpg","webp_source":"https://content.protocols.io/files/pxjg5yye.webp"},"note":"","is_verified_user":true},{"name":"Holly Spence","affiliation":"University of Aberdeen","affiliation_url":null,"username":"holly-spence","link":"","image":{"source":"/img/avatars/014.png","placeholder":"/img/avatars/014.png","webp_source":""},"note":"","is_verified_user":true},{"name":"Jenna Gregory","affiliation":"University of Aberdeen","affiliation_url":null,"username":"jenna-gregory","link":"","image":{"source":"/img/avatars/006.png","placeholder":"/img/avatars/006.png","webp_source":""},"note":"","is_verified_user":true}],"before_start":"{\"blocks\":[{\"key\":\"ar8o5\",\"text\":\"Please see appendix for materials required to carry out this protocol.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_manage_keywords":true,"can_remove_fork":false,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[],"created_on":1709306456,"creator":{"name":"Jenna Gregory","affiliation":"University of Aberdeen","affiliation_url":null,"username":"jenna-gregory","link":"","image":{"source":"/img/avatars/006.png","placeholder":"/img/avatars/006.png","webp_source":""},"badges":[{"id":3,"name":"Power author!","image":{"source":"/img/badges/silver.svg","placeholder":"/img/badges/silver.svg"}}],"affiliations":[{"affiliation":"University of Aberdeen","url":null,"job_title":null,"is_default":true}]},"cross_cloud_origin":null,"description":"{\"blocks\":[{\"key\":\"75rri\",\"text\":\"Here we provide a SOP to outline the correct procedures for performing Immunohistochemistry (IHC) to detect pathological TDP-43 in FFPE-preserved human tissue using the TDP-43 RNA Aptamer, as described in Spence and Waldron et al., 2024 published in Acta Neuropathologica (DOI: 10.1007/s00401-024-02705-1).\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":224,\"length\":5},{\"style\":\"italic\",\"offset\":250,\"length\":21}],\"entityRanges\":[],\"data\":{}},{\"key\":\"efdl7\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"983ei\",\"text\":\"Users with access to Sequenza immunostaining racks and histological facilities (with fume hood) should be able to carry out all steps over two days.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"13gg7\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"fkmhk\",\"text\":\"This protocol uses the TDP-43APT sequence published in Zacco et al., 2022. The sequence is: CGGUGUUGCU with a  3' Biotin-TEG modification, purified using HPLC, scale: 1.0 µM synthesis.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":29,\"length\":3},{\"style\":\"italic\",\"offset\":61,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"fklh9\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"15qgh\",\"text\":\" \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"acn86\",\"text\":\"References for citation of this method\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":38},{\"style\":\"UNDERLINE\",\"offset\":0,\"length\":38}],\"entityRanges\":[],\"data\":{}},{\"key\":\"3uqc\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"8ok0e\",\"text\":\"Please cite both of these below if using this method:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9tubm\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"23eog\",\"text\":\"The citation, Spence and Waldron et al., 2024, for the first publication for the development, modification and employment of theTDP-43 RNA aptamer to stain human tissue published in Acta Neuropathologica.\\n\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":0,\"length\":204}],\"entityRanges\":[],\"data\":{}},{\"key\":\"ar0nh\",\"text\":\"RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":162}],\"entityRanges\":[],\"data\":{}},{\"key\":\"eqduh\",\"text\":\"Holly Spence*, Fergal M. Waldron*, Rebecca S. Saleeb, Anna-Leigh Brown, Olivia M. Rifai, Martina Gilodi, Fiona Read, Kristine, Roberts, Gillian Milne, Debbie Wilkinson, Judi O’Shaughnessy, Annalisa Pastore, Pietro Fratta, Neil Shneider, Gian Gaetano Tartaglia, Elsa Zacco, Mathew H. Horrocks, Jenna M. Gregory‡. Acta Neuropathologica 2024 Mar 5;147(1):50. DOI: 10.1007/s00401-024-02705-1. *equal contributions, ‡corresponding author.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":309,\"length\":1},{\"style\":\"sup\",\"offset\":411,\"length\":1},{\"style\":\"italic\",\"offset\":312,\"length\":22}],\"entityRanges\":[],\"data\":{}},{\"key\":\"csjdt\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"fl1a\",\"text\":\"The citation, Waldron and Spence et al., 2024, for this SOP published on protocols.io is:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":0,\"length\":89}],\"entityRanges\":[],\"data\":{}},{\"key\":\"cttq9\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9t3d7\",\"text\":\"TDP-43 RNA aptamer staining to detect pathological TDP-43 in FFPE human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica): A SOP and tick-sheet. v2.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":178}],\"entityRanges\":[],\"data\":{}},{\"key\":\"1k0q6\",\"text\":\"Fergal M. Waldron*, Holly Spence*, Jenna M. Gregory‡. protocols.io 2024; \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":51,\"length\":1},{\"style\":\"italic\",\"offset\":54,\"length\":12}],\"entityRanges\":[],\"data\":{}},{\"key\":\"drakr\",\"text\":\"DOI: dx.doi.org/10.17504/protocols.io.eq2lyjo4mlx9/v2. *equal contributions, ‡corresponding author.     \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":77,\"length\":1}],\"entityRanges\":[],\"data\":{}},{\"key\":\"cq7og\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","disclaimer":"{\"blocks\":[{\"key\":\"94lq9\",\"text\":\"Authors declare no conflicts of interest.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","document":"","documents":[{"id":480804,"guid":"","type_id":0,"filename":"","key":"","color":"","height":0,"width":0,"is_document":null,"original_file_id":null,"thumb_url":"https://www.protocols.io/img/extensions/pdf.png","size":305578,"is_private":0,"is_new":0,"ofn":"TDP-43 RNA Aptamer_IHC _SOP_v2.0_July24.pdf","url":"https://content.protocols.io/files/qxte6dan.pdf","bucket_name":null,"s3_webp_url":"","file_id":480804},{"id":480805,"guid":"","type_id":0,"filename":"","key":"","color":"","height":0,"width":0,"is_document":null,"original_file_id":null,"thumb_url":"https://www.protocols.io/img/extensions/pdf.png","size":235048,"is_private":0,"is_new":0,"ofn":"TDP-43 RNA Aptamer_IHC_TS_v2.0_July24.pdf","url":"https://content.protocols.io/files/qxtf6dan.pdf","bucket_name":null,"s3_webp_url":"","file_id":480805}],"doi":"dx.doi.org/10.17504/protocols.io.eq2lyjo4mlx9/v2","doi_status":1,"ethics_statement":"","fork_id":null,"fork_info":null,"forks":[],"funders":[{"funder_name":"Target ALS","grant_id":"BB-2022-C4-L2"}],"groups":[{"id":19372,"uri":"gregory-lab","title":"Gregory Lab","is_public":false,"image":{"source":"https://s3.amazonaws.com/protocols-files/files/894186B22A9211EC96350A58A9FEAC02-placeholder.png","placeholder":"https://s3.amazonaws.com/protocols-files/files/894186B22A9211EC96350A58A9FEAC02-placeholder.png"},"tech_support":{"email":null,"phone":null,"use_email":false,"hide_contact":false,"url":null}}],"guid":"65D7E60A39F111EFBA840A58A9FEAC02","guidelines":"{\"blocks\":[{\"key\":\"63a71\",\"text\":\"This protocol is designed for users with access to Sequenza immunostaining racks and histological facilities (with fume hood) should be able to carry out all steps over two days.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","has_references":true,"has_step_reagents":false,"has_versions":true,"id":102860,"image":{"source":"https://content.protocols.io/files/pyp36dan.svg","webp_source":"","placeholder":"https://content.protocols.io/files/pyp46dan.svg","webp_placeholder":""},"image_attribution":"{\"blocks\":[{\"key\":\"8np5s\",\"text\":\"Jenna M Gregory\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_doi_reserved":true,"is_in_pending_publishing":false,"is_in_transfer":false,"is_owner":true,"is_research":true,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":1268582,"journal":{"journal_id":"https://doi.org/10.1007/s00401-024-02705-1","name":"Acta Neuropathologica","group_id":1,"link":"https://link.springer.com/article/10.1007/s00401-024-02705-1","citation":"\u003cp\u003eSpence, H., Waldron, F.M., Saleeb, R.S. \u003cem\u003eet al.\u003c/em\u003e RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with \u003cem\u003eSTMN-2\u003c/em\u003e cryptic splicing and precedes clinical manifestation in ALS. \u003cem\u003eActa Neuropathol\u003c/em\u003e \u003cstrong\u003e147\u003c/strong\u003e, 50 (2024).\u003c/p\u003e","is_main":true},"journals":[{"journal_id":"https://doi.org/10.1007/s00401-024-02705-1","name":"Acta Neuropathologica","group_id":1,"link":"https://link.springer.com/article/10.1007/s00401-024-02705-1","citation":"\u003cp\u003eSpence, H., Waldron, F.M., Saleeb, R.S. \u003cem\u003eet al.\u003c/em\u003e RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with \u003cem\u003eSTMN-2\u003c/em\u003e cryptic splicing and precedes clinical manifestation in ALS. \u003cem\u003eActa Neuropathol\u003c/em\u003e \u003cstrong\u003e147\u003c/strong\u003e, 50 (2024).\u003c/p\u003e","is_main":true}],"keywords":"ALS,MND,FTD,ALSFTSD,TDP-43,RNA aptamer,Human tissue staining,Immunohistochemistry","last_modified":1720091721,"link":"","location":null,"manuscript_citation":"{\"blocks\":[{\"key\":\"100ed\",\"text\":\"References for citation of this method\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":38},{\"style\":\"UNDERLINE\",\"offset\":0,\"length\":38}],\"entityRanges\":[],\"data\":{}},{\"key\":\"aivj1\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"1fikr\",\"text\":\"Please cite both of these below if using this method:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2kuu9\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bannv\",\"text\":\"The citation, Spence and Waldron et al., 2024, for the first publication for the development, modification and employment of theTDP-43 RNA aptamer to stain human tissue published in Acta Neuropathologica.\\n\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":0,\"length\":204}],\"entityRanges\":[],\"data\":{}},{\"key\":\"dfhgo\",\"text\":\"RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":162}],\"entityRanges\":[],\"data\":{}},{\"key\":\"epldp\",\"text\":\"Holly Spence*, Fergal M. Waldron*, Rebecca S. Saleeb, Anna-Leigh Brown, Olivia M. Rifai, Martina Gilodi, Fiona Read, Kristine, Roberts, Gillian Milne, Debbie Wilkinson, Judi O’Shaughnessy, Annalisa Pastore, Pietro Fratta, Neil Shneider, Gian Gaetano Tartaglia, Elsa Zacco, Mathew H. Horrocks, Jenna M. Gregory‡. Acta Neuropathologica 2024 Mar 5;147(1):50. DOI: 10.1007/s00401-024-02705-1. *equal contributions, ‡corresponding author.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":309,\"length\":1},{\"style\":\"sup\",\"offset\":411,\"length\":1},{\"style\":\"italic\",\"offset\":312,\"length\":22}],\"entityRanges\":[],\"data\":{}},{\"key\":\"3klma\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9622c\",\"text\":\"The citation, Waldron and Spence et al., 2024, for this SOP published on protocols.io is:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":0,\"length\":89}],\"entityRanges\":[],\"data\":{}},{\"key\":\"5b3tp\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"5ghmn\",\"text\":\"TDP-43 RNA aptamer staining to detect pathological TDP-43 in FFPE human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica): A SOP and tick-sheet. v2.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":178}],\"entityRanges\":[],\"data\":{}},{\"key\":\"c9q8l\",\"text\":\"Fergal M. Waldron*, Holly Spence*, Jenna M. Gregory‡. protocols.io 2024; \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":51,\"length\":1},{\"style\":\"italic\",\"offset\":54,\"length\":12}],\"entityRanges\":[],\"data\":{}},{\"key\":\"a0b7\",\"text\":\"DOI: dx.doi.org/10.17504/protocols.io.eq2lyjo4mlx9/v2. *equal contributions, ‡corresponding author. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":77,\"length\":1}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","materials":[],"materials_text":"{\"blocks\":[{\"key\":\"7mpcn\",\"text\":\"See SOP appendix for materials.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","ownership_history":null,"parent_collections":[],"parent_protocols":[],"peer_reviewed":false,"protocol_references":"{\"blocks\":[{\"key\":\"6n68v\",\"text\":\"References for citation of this method\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":38},{\"style\":\"UNDERLINE\",\"offset\":0,\"length\":38}],\"entityRanges\":[],\"data\":{}},{\"key\":\"de2nu\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"71u16\",\"text\":\"Please cite both of these below if using this method:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ccgf6\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9cgcg\",\"text\":\"The citation, Spence and Waldron et al., 2024, for the first publication for the development, modification and employment of theTDP-43 RNA aptamer to stain human tissue published in Acta Neuropathologica.\\n\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":0,\"length\":204}],\"entityRanges\":[],\"data\":{}},{\"key\":\"e36d3\",\"text\":\"RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":162}],\"entityRanges\":[],\"data\":{}},{\"key\":\"dmlpn\",\"text\":\"Holly Spence*, Fergal M. Waldron*, Rebecca S. Saleeb, Anna-Leigh Brown, Olivia M. Rifai, Martina Gilodi, Fiona Read, Kristine, Roberts, Gillian Milne, Debbie Wilkinson, Judi O’Shaughnessy, Annalisa Pastore, Pietro Fratta, Neil Shneider, Gian Gaetano Tartaglia, Elsa Zacco, Mathew H. Horrocks, Jenna M. Gregory‡. Acta Neuropathologica 2024 Mar 5;147(1):50. DOI: 10.1007/s00401-024-02705-1. *equal contributions, ‡corresponding author.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":309,\"length\":1},{\"style\":\"sup\",\"offset\":411,\"length\":1},{\"style\":\"italic\",\"offset\":312,\"length\":22}],\"entityRanges\":[],\"data\":{}},{\"key\":\"bhj3n\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ft62h\",\"text\":\"The citation, Waldron and Spence et al., 2024, for this SOP published on protocols.io is:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":0,\"length\":89}],\"entityRanges\":[],\"data\":{}},{\"key\":\"c2lur\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"5r958\",\"text\":\"TDP-43 RNA aptamer staining to detect pathological TDP-43 in FFPE human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica): A SOP and tick-sheet. v2.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":178}],\"entityRanges\":[],\"data\":{}},{\"key\":\"ce7l2\",\"text\":\"Fergal M. Waldron*, Holly Spence*, Jenna M. Gregory‡. protocols.io 2024; \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":51,\"length\":1},{\"style\":\"italic\",\"offset\":54,\"length\":12}],\"entityRanges\":[],\"data\":{}},{\"key\":\"dihfm\",\"text\":\"DOI: dx.doi.org/10.17504/protocols.io.eq2lyjo4mlx9/v2. *equal contributions, ‡corresponding author. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"sup\",\"offset\":77,\"length\":1}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","public":true,"public_fork_note":"","published_on":1720091721,"references":[],"related_equipments":[],"related_materials":[],"reserved_doi":"10.17504/protocols.io.eq2lyjo4mlx9/v2","retraction_reason":null,"samples":{},"shared_access_id":265,"show_comparison":true,"sign_info":null,"space_access":{"can_view":false,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":true,"can_get_doi":true,"can_share":false,"can_move":false,"can_move_outside":false,"can_transfer":false,"can_download":false,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"space_id":19215,"state_version_id":157,"stats":{"is_voted":false,"number_of_views":466,"number_of_steps":0,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":0,"number_of_equipments":0,"number_of_collections":0,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":1,"info":"We use this protocol and it's working"},"steps":null,"template_id":0,"title":"TDP-43 RNA aptamer staining to detect pathological TDP-43 in FFPE human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica): A SOP and tick-sheet. v2.","title_html":"TDP-43 RNA aptamer staining to detect pathological TDP-43 in FFPE human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica): A SOP and tick-sheet. v2.","type_id":1,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0,"read_only":0},{"id":2,"type_id":3,"name":"mL","can_manage":0,"read_only":0},{"id":3,"type_id":3,"name":"L","can_manage":0,"read_only":0},{"id":4,"type_id":3,"name":"µg","can_manage":0,"read_only":0},{"id":5,"type_id":3,"name":"mg","can_manage":0,"read_only":0},{"id":6,"type_id":3,"name":"g","can_manage":0,"read_only":0},{"id":7,"type_id":3,"name":"kg","can_manage":0,"read_only":0},{"id":8,"type_id":3,"name":"ng","can_manage":0,"read_only":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0,"read_only":0},{"id":10,"type_id":24,"name":"°C","can_manage":0,"read_only":0},{"id":11,"type_id":24,"name":"°К","can_manage":0,"read_only":0},{"id":12,"type_id":24,"name":"°F","can_manage":0,"read_only":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0,"read_only":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0,"read_only":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0,"read_only":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0,"read_only":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0,"read_only":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0,"read_only":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0,"read_only":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0,"read_only":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0,"read_only":1},{"id":22,"type_id":25,"name":"Molarity (M)","can_manage":0,"read_only":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0,"read_only":0},{"id":24,"type_id":3,"name":"μV","can_manage":0,"read_only":0},{"id":25,"type_id":3,"name":"ms","can_manage":0,"read_only":0},{"id":26,"type_id":3,"name":"pg","can_manage":0,"read_only":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0,"read_only":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0,"read_only":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0,"read_only":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0,"read_only":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0,"read_only":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0,"read_only":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0,"read_only":0},{"id":34,"type_id":30,"name":"x g","can_manage":0,"read_only":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0,"read_only":0},{"id":200,"type_id":32,"name":"cm","can_manage":0,"read_only":0},{"id":201,"type_id":32,"name":"mm","can_manage":0,"read_only":0},{"id":202,"type_id":32,"name":"µm","can_manage":0,"read_only":0},{"id":203,"type_id":32,"name":"nm","can_manage":0,"read_only":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0,"read_only":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0,"read_only":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0,"read_only":0},{"id":207,"type_id":3,"name":"V","can_manage":0,"read_only":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0,"read_only":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0,"read_only":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0,"read_only":0}],"uri":"tdp-43-rna-aptamer-staining-to-detect-pathological-dgpk3vkw","url":"https://www.protocols.io/view/tdp-43-rna-aptamer-staining-to-detect-pathological-dgpk3vkw","version_class":96023,"version_data":{"id":1,"code":"dgpk3vkw","version_class":96023,"parent_id":96023,"parent_uri":"sop-and-tick-sheet-for-using-tdp-43-rna-aptamer-td-c9zxz77n","is_same_owner":true,"is_parent_public":true,"has_pending_merge_request":false,"has_approved_merge_request":true,"merge_request":{"id":2804,"creator":{"name":"Jenna Gregory","affiliation":"University of Aberdeen","affiliation_url":null,"username":"jenna-gregory","link":"","image":{"source":"/img/avatars/006.png","placeholder":"/img/avatars/006.png","webp_source":""}},"created_on":1720090926,"can_manage":true}},"version_id":1,"version_uri":"tdp-43-rna-aptamer-staining-to-detect-pathological-eq2lyjo4mlx9/v2","versions":[{"id":96023,"title":"SOP and tick-sheet for using TDP-43 RNA aptamer (TDP-43APT) to detect pathological TDP-43 in FFPE-preserved human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica)","title_html":"SOP and tick-sheet for using TDP-43 RNA aptamer (TDP-43APT) to detect pathological TDP-43 in FFPE-preserved human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica)","image":{"source":"https://content.protocols.io/files/pyp36dan.svg","webp_source":null,"placeholder":"https://content.protocols.io/files/pyp36dan.svg","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.eq2lyjo4mlx9/v1","uri":"sop-and-tick-sheet-for-using-tdp-43-rna-aptamer-td-c9zxz77n","published_on":1709310700,"modified_on":1709310700,"version_class":96023,"version_id":0,"version_code":"c9zxz77n","version_uri":"sop-and-tick-sheet-for-using-tdp-43-rna-aptamer-td-eq2lyjo4mlx9/v1","created_on":1709306456,"categories":null,"type_id":1,"creator":{"name":"Jenna Gregory","affiliation":"University of Aberdeen","affiliation_url":null,"username":"jenna-gregory","link":"","image":{"source":"/img/avatars/006.png","placeholder":"/img/avatars/006.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}},{"id":102860,"title":"TDP-43 RNA aptamer staining to detect pathological TDP-43 in FFPE human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica): A SOP and tick-sheet. v2.","title_html":"TDP-43 RNA aptamer staining to detect pathological TDP-43 in FFPE human tissue, as described in Spence and Waldron et al., 2024 (Acta Neuropathologica): A SOP and tick-sheet. v2.","image":{"source":"https://content.protocols.io/files/pyp36dan.svg","webp_source":null,"placeholder":"https://content.protocols.io/files/pyp36dan.svg","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.eq2lyjo4mlx9/v2","uri":"tdp-43-rna-aptamer-staining-to-detect-pathological-dgpk3vkw","published_on":1720091721,"modified_on":1720091721,"version_class":96023,"version_id":1,"version_code":"dgpk3vkw","version_uri":"tdp-43-rna-aptamer-staining-to-detect-pathological-eq2lyjo4mlx9/v2","created_on":1709306456,"categories":null,"type_id":1,"creator":{"name":"Jenna Gregory","affiliation":"University of Aberdeen","affiliation_url":null,"username":"jenna-gregory","link":"","image":{"source":"/img/avatars/006.png","placeholder":"/img/avatars/006.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":"{\"blocks\":[{\"key\":\"tran\",\"text\":\"Safety First\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":12},{\"style\":\"UNDERLINE\",\"offset\":0,\"length\":12}],\"entityRanges\":[],\"data\":{}},{\"key\":\"dcgut\",\"text\":\"Before starting, please ensure all relevant Health \\u0026 Safety documentation is in order including the following\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9hm6k\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"999aj\",\"text\":\"- COSHH assessment\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bfjv0\",\"text\":\"-  Risk assessment\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7ll6s\",\"text\":\"-  Safe System of Work \\n- SOP read and understood\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}"}